How to administer insulin degludec (insulin degludec)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Administer Insulin Degludec

Insulin degludec should be administered subcutaneously once daily at any time of day, with flexibility in timing allowed due to its ultra-long action profile of approximately 25 hours. 1, 2

Administration Technique

  • Insulin degludec is administered via subcutaneous injection into the thigh, upper arm, or abdomen 1
  • Prior to injection, visually inspect the insulin - it should appear clear and colorless 1
  • Do not shake or roll the vial before drawing up the medication 1
  • Injection sites should be rotated within the same anatomical region to reduce the risk of lipodystrophy and localized cutaneous amyloidosis 1
  • Insulin degludec should not be diluted or mixed with any other insulin products 1

Dosing Considerations

  • For insulin-naïve patients with type 2 diabetes, the recommended starting dose is 10 units once daily 3
  • For patients already on insulin therapy who are switching to degludec, consider the previous basal insulin dose when initiating 3
  • For patients receiving enteral feedings who require basal insulin, a starting dose of 10 units of insulin degludec daily is recommended 3
  • Dose adjustments should be based on blood glucose monitoring results and individualized glycemic targets 3

Unique Features and Advantages

  • Unlike other basal insulins, insulin degludec allows for flexible dosing times without compromising efficacy or safety 4, 2
  • Studies have shown that insulin degludec can be administered at different times from day to day (with intervals between 8-40 hours) while maintaining glycemic control 2
  • This flexibility may be particularly beneficial for patients with irregular schedules, those who travel frequently, or those dependent on healthcare professionals for insulin administration 4

Safety Considerations

  • Insulin degludec has demonstrated a lower risk of nocturnal hypoglycemia compared to insulin glargine in clinical trials 5, 6
  • The ultra-long action profile creates a steady-state profile with a lower peak-to-trough ratio than other basal insulins 4
  • As with all insulins, patients should be educated about recognizing and managing hypoglycemia 3
  • Patients should carry at least 15g of carbohydrate to treat potential hypoglycemic episodes 3

Storage and Handling

  • Unopened insulin degludec vials should be stored in the refrigerator at 36°F to 46°F (2°C to 8°C) 1
  • Once in use, insulin degludec vials can be stored at room temperature for up to 56 days 1
  • Do not use insulin degludec past the expiration date or beyond 56 days after first use 1

Special Situations

  • For perioperative management, administer 60-80% of the usual degludec dose on the day of surgery 3
  • For patients with type 1 diabetes, insulin degludec must be used in combination with mealtime insulin 5
  • For patients receiving continuous enteral feedings, insulin degludec can be administered once daily as the basal component of an insulin regimen 3

Remember that regular blood glucose monitoring is essential for appropriate dose adjustments and optimal glycemic control when using insulin degludec 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.